Company Description
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.
It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected.
The company’s develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes.
The company was founded in 2014 and is based in Kirkland, Washington.
| Country | United States |
| Founded | 2014 |
| IPO Date | Mar 6, 2025 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 330 |
| CEO | Brian Webster |
Contact Details
Address: 3933 Lake Washington Blvd NE, Suite 200 Kirkland, Washington 98033 United States | |
| Phone | 425 279 8002 |
| Website | kestramedical.com |
Stock Details
| Ticker Symbol | KMTS |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001877184 |
| ISIN Number | BMG524411052 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Brian Webster | Founder, President, Chief Executive Officer and Director |
| Traci S. Umberger | Co-Founder, General Counsel, Chief Administrative Officer, Secretary and Director |
| Vaseem Mahboob | Chief Financial Officer |
| Gordon Teddy | Chief Information Officer |
| Neil Bhalodkar | Vice President of Investor Relations |
| Debra Schotz | Senior Vice President of Marketing |
| Jeffrey Laub | Senior Vice President of Operations |
| Phillip D. Foshee Jr. | Senior Vice President of Research and Development |
| Alfred J. Ford Jr. | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 22, 2025 | ARS | Filing |
| Jul 22, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Jul 22, 2025 | DEF 14A | Other definitive proxy statements |
| Jul 17, 2025 | 10-K | Annual Report |
| Jul 15, 2025 | 8-K | Current Report |
| Jun 6, 2025 | 8-K | Current Report |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 15, 2025 | SCHEDULE 13G | Filing |
| May 12, 2025 | SCHEDULE 13G | Filing |
| Apr 17, 2025 | 10-Q | Quarterly Report |